Información:
Error:
ID
14798
Descripción
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor; ODM derived from: https://clinicaltrials.gov/show/NCT00754325
Link
https://clinicaltrials.gov/show/NCT00754325
Palabras clave
Versiones (1)
- 28/4/16 28/4/16 -
Subido en
28 de abril de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Advanced Breast Cancer NCT00754325
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
Similar models
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
hormone receptor positive breast cancer
Item
histologically confirmed hormone receptor positive (hr+) [(estrogen receptor (er+) and/or progesterone receptors(pgr+)] breast cancer according to immunohistochemistry (ihc)
boolean
C1562029 (UMLS CUI [1])
measureable disease
Item
measureable or evaluable-only disease
boolean
C1513041 (UMLS CUI [1])
epidermal growth factor receptor breast cancer
Item
human epidermal growth factor receptor 2+ (her2+) or her2- breast cancer
boolean
C1960925 (UMLS CUI [1])
age
Item
males and females ≥18 years of age
boolean
C0001779 (UMLS CUI [1])
post menopausal or surgically sterile
Item
females are post menopausal or surgically sterile
boolean
C0021359 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
recurrent or progressive advanced breast cancer
Item
recurrent or progressive advanced breast cancer (locally-advanced or metastatic), that has progressed: (a) during or within 12 months after completion of adjuvant aromatase inhibitor (ai) treatment or (b) during ai treatment in advanced setting (metastatic therapy)
boolean
C0596224 (UMLS CUI [1])
pregnant or breast feeding
Item
pregnant or breast feeding
boolean
C0549206 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
chemotherapy regimen
Item
>1 chemotherapy regimen for advanced disease
boolean
C0392920 (UMLS CUI [1])
pleural or pericardial effusion
Item
pleural or pericardial effusion
boolean
C0032227 (UMLS CUI [1])
C0031039 (UMLS CUI [2])
C0031039 (UMLS CUI [2])
cardiac condition
Item
serious cardiac condition
boolean
C0018799 (UMLS CUI [1])